As part of the Research Investments in Global Health study (ResIn, www.researchinvestments.org), you may be interested in this our recent paper, led by colleague Joseph Fitchett and with Rifat Atun as senior author – we described funding for ebola R&D in the years prior to the 2014 outbreak and the responsive funding during the first year of the outbreak, covering $1 billion of investments from US and UK government, Wellcome, Gates etc. We’ve charted the funder, destination of those funds, and what they’re for (e.g. vaccine, diagnostics, therapeutics).
Now published ‘online first’ at Journal of Global Health
Paper is here – http://www.jogh.org/documents/issue201602/jogh-06-020703.XML